16 results
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
antitrust laws as promptly as reasonably practicable following the date of the merger agreement, (ii) supplying as promptly as practicable any additional … information and documentary material required pursuant to any antitrust law and (iii) satisfying certain regulatory matters. No filings under the Hart
S-4/A
ADAP
Adaptimmune Therapeutics Plc
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
in connection with the merger and the other transactions contemplated by the merger agreement, including (i) making any filings required by applicable antitrust … information and documentary material required pursuant to any antitrust law and (iii) satisfying certain regulatory matters. No filings under the Hart-Scott
S-4
ADAP
Adaptimmune Therapeutics Plc
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
by applicable antitrust laws as promptly as reasonably practicable following the date of the merger agreement, (ii) supplying as promptly as practicable any … additional information and documentary material required pursuant to any antitrust law and (iii) satisfying certain regulatory matters. No filings under
8-K
EX-99.1
bpo0p sqo
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
aq4 iellm
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
in4tx alg
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
10-K
jixorwmlubx1b9yvk9
13 Mar 17
Annual report
12:00am
20-F
fbpfr y5r9lddbkb5pi
13 Oct 15
Annual report (foreign)
12:00am
DRS
EX-10.3
nl8jit dyk
5 Feb 15
Draft registration statement
12:00am
DRS
EX-10.4
vjfj lkp13onj9nft
5 Feb 15
Draft registration statement
12:00am
- Prev
- 1
- Next